Expansion of CD16-Negative Natural Killer Cells in the Peripheral Blood of Patients with Metastatic Melanoma

<table>CD9 expression on NK cells in patients with melanoma. Scatterplot demonstrating CD9 expression in a subset of peripheral blood CD16− NK cells from patients with metastatic melanoma (right).  CD9, a marker specific for decidual NK cells is, absent on NK cells from healthy individuals (left). Gating is set on CD3− CD56+ lymphocytes. Numbers represent percentages of total NK cells in each quadrant.</table>

Journal of Immunology Research

fig3

Figure 3

Figure 3: Expansion of CD16-Negative Natural Killer Cells in the Peripheral Blood of Patients with Metastatic Melanoma 